BioRx Receives URAC Specialty Pharmacy Accreditation
CINCINNATI, Ohio (August 13, 2014) – BioRx announced today that it has been awarded Specialty Pharmacy accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry. BioRx is a highly specialized pharmacy and infusion services provider that secures necessary treatments for patients with ultra-orphan and rare, chronic diseases.
URAC's Specialty Pharmacy accreditation provides an external validation of excellence in specialty pharmacy management and provides continuous quality improvement (CQI) oriented processes that improve operations and enhance compliance. Specialty pharmaceuticals are those that typically require special handling, administration, unique inventory management, and a high level of patient monitoring and support. URAC ensures that all stakeholders are represented in establishing meaningful quality measures supported by evidence-based practice for the entire healthcare industry.
"We are extremely proud to receive specialty pharmacy accreditation from URAC," said Eric Hill, co-founder of BioRx. "Pursuing and achieving URAC accreditation, in addition to our current ACHC accreditation, exemplifies our ongoing commitment to meet standards of quality in everything that we do. Ultimately, it creates an opportunity for us to continually improve and enhance our services."
Specialty medications typically require lifelong clinical and educational support for home or self-administration. BioRx maximizes therapeutic outcomes from select, high-cost specialty drugs. The company's portfolio includes a number of open-source and limited distribution therapies for hemophilia, primary immune deficiency, autoimmune disorders, hereditary angioedema, and alpha-1 antitrypsin deficiency.
"By applying for and receiving URAC accreditation, BioRx has demonstrated a commitment to quality healthcare," said URAC President and CEO, Kylanne Green. "Quality healthcare is crucial to our nation's welfare and it is important to have organizations that are willing to measure themselves against national standards and undergo rigorous evaluation by an independent accrediting body."
Download news release (PDF)
URAC, an independent, nonprofit organization, is a leader in promoting health care quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the healthcare system, and provide a mark of distinction for healthcare organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the health care industry. For more information, visit www.urac.org.
Based in Cincinnati, Ohio, BioRx is one of the nation’s fastest growing providers of specialty pharmaceuticals and infusion services, delivering highly customized care for patients with certain rare and chronic diseases. In addition to serving patients with alpha-1 antitrypsin deficiency, BioRx offers pharmacy, nursing and education services to patients with hemophilia, primary immune deficiencies, autoimmune disorders, and hereditary angioedema. The company’s clinical staff reaches patients and physicians in all 50 states. To learn more about BioRx and its products and services, visit www.biorx.com.